These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
440 related articles for article (PubMed ID: 26306900)
1. Primary Cutaneous B-Cell Lymphoma: Management and Patterns of Recurrence at the Multimodality Cutaneous Lymphoma Clinic of The Ohio State University. Haverkos B; Tyler K; Gru AA; Winardi FK; Frederickson J; Hastings J; Elkins C; Zhang X; Xu-Welliver M; Wong HK; Porcu P Oncologist; 2015 Oct; 20(10):1161-6. PubMed ID: 26306900 [TBL] [Abstract][Full Text] [Related]
2. Primary cutaneous marginal zone B-cell lymphoma: response to treatment and disease-free survival in a series of 137 patients. Servitje O; Muniesa C; Benavente Y; Monsálvez V; Garcia-Muret MP; Gallardo F; Domingo-Domenech E; Lucas A; Climent F; Rodriguez-Peralto JL; Ortiz-Romero PL; Sandoval J; Pujol RM; Estrach MT J Am Acad Dermatol; 2013 Sep; 69(3):357-65. PubMed ID: 23796549 [TBL] [Abstract][Full Text] [Related]
3. Primary cutaneous B-cell lymphomas: part II. Therapy and future directions. Suárez AL; Querfeld C; Horwitz S; Pulitzer M; Moskowitz A; Myskowski PL J Am Acad Dermatol; 2013 Sep; 69(3):343.e1-11; quiz 355-6. PubMed ID: 23957985 [TBL] [Abstract][Full Text] [Related]
4. Primary cutaneous B-cell lymphomas: recent advances in diagnosis and management. Sokol L; Naghashpour M; Glass LF Cancer Control; 2012 Jul; 19(3):236-44. PubMed ID: 22710899 [TBL] [Abstract][Full Text] [Related]
5. Clinical features and treatment outcomes of primary cutaneous B-cell lymphoma: a single-center analysis in South Korea. Kim MJ; Hong ME; Maeng CH; Jung HA; Hong JY; Choi MK; Kim SJ; Ko YH; Kim WS Int J Hematol; 2015 Mar; 101(3):273-8. PubMed ID: 25552248 [TBL] [Abstract][Full Text] [Related]
7. Primary cutaneous B-cell lymphomas - clinicopathological, prognostic and therapeutic characterisation of 54 cases according to the WHO-EORTC classification and the ISCL/EORTC TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sezary syndrome. Golling P; Cozzio A; Dummer R; French L; Kempf W Leuk Lymphoma; 2008 Jun; 49(6):1094-103. PubMed ID: 18569636 [TBL] [Abstract][Full Text] [Related]
8. The value of molecular diagnostics in primary cutaneous B-cell lymphomas in the context of clinical findings, histology, and immunohistochemistry. Felcht M; Booken N; Stroebel P; Goerdt S; Klemke CD J Am Acad Dermatol; 2011 Jan; 64(1):135-43, 143.e1-4. PubMed ID: 21167409 [TBL] [Abstract][Full Text] [Related]
9. Primary cutaneous B-cell lymphomas: part I. Clinical features, diagnosis, and classification. Suárez AL; Pulitzer M; Horwitz S; Moskowitz A; Querfeld C; Myskowski PL J Am Acad Dermatol; 2013 Sep; 69(3):329.e1-13; quiz 341-2. PubMed ID: 23957984 [TBL] [Abstract][Full Text] [Related]
10. Cutaneous lymphomas: an update. Part 2: B-cell lymphomas and related conditions. Kempf W; Kazakov DV; Mitteldorf C Am J Dermatopathol; 2014 Mar; 36(3):197-208; quiz 209-10. PubMed ID: 24658377 [TBL] [Abstract][Full Text] [Related]
11. Prognostic factors in primary cutaneous B-cell lymphoma: the Italian Study Group for Cutaneous Lymphomas. Zinzani PL; Quaglino P; Pimpinelli N; Berti E; Baliva G; Rupoli S; Martelli M; Alaibac M; Borroni G; Chimenti S; Alterini R; Alinari L; Fierro MT; Cappello N; Pileri A; Soligo D; Paulli M; Pileri S; Santucci M; Bernengo MG; J Clin Oncol; 2006 Mar; 24(9):1376-82. PubMed ID: 16492713 [TBL] [Abstract][Full Text] [Related]
12. Rituximab plus liposomal pegylated doxorubicin in the treatment of primary cutaneous B-cell lymphomas. Fabbri A; Cencini E; Alterini R; Rubegni P; Rigacci L; Delfino C; Puccini B; Fimiani M; Bosi A; Bocchia M; Pimpinelli N; Eur J Haematol; 2014 Aug; 93(2):129-36. PubMed ID: 24635751 [TBL] [Abstract][Full Text] [Related]
13. The applicability and prognostic value of the new TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sézary syndrome: results on a large cohort of primary cutaneous B-cell lymphomas and comparison with the system used by the Dutch Cutaneous Lymphoma Group. Senff NJ; Willemze R Br J Dermatol; 2007 Dec; 157(6):1205-11. PubMed ID: 17941944 [TBL] [Abstract][Full Text] [Related]
15. Treatment and outcomes in patients with primary cutaneous B-cell lymphoma: the BC Cancer Agency experience. Hamilton SN; Wai ES; Tan K; Alexander C; Gascoyne RD; Connors JM Int J Radiat Oncol Biol Phys; 2013 Nov; 87(4):719-25. PubMed ID: 24001373 [TBL] [Abstract][Full Text] [Related]
16. Cutaneous B-cell lymphoma: important diagnostic tools. Ferenczi K G Ital Dermatol Venereol; 2010 Jun; 145(3):361-73. PubMed ID: 20461044 [TBL] [Abstract][Full Text] [Related]
17. Cutaneous B-cell lymphomas: 2015 update on diagnosis, risk-stratification, and management. Wilcox RA Am J Hematol; 2015 Jan; 90(1):73-6. PubMed ID: 25535037 [TBL] [Abstract][Full Text] [Related]
18. Primary cutaneous B-cell lymphomas. Current concepts. I. Santucci M; Pimpinelli N Haematologica; 2004 Nov; 89(11):1360-71. PubMed ID: 15531459 [TBL] [Abstract][Full Text] [Related]
19. Reclassification of 300 primary cutaneous B-Cell lymphomas according to the new WHO-EORTC classification for cutaneous lymphomas: comparison with previous classifications and identification of prognostic markers. Senff NJ; Hoefnagel JJ; Jansen PM; Vermeer MH; van Baarlen J; Blokx WA; Canninga-van Dijk MR; Geerts ML; Hebeda KM; Kluin PM; Lam KH; Meijer CJ; Willemze R J Clin Oncol; 2007 Apr; 25(12):1581-7. PubMed ID: 17353548 [TBL] [Abstract][Full Text] [Related]
20. Cutaneous B-cell lymphomas: 2019 update on diagnosis, risk stratification, and management. Wilcox RA Am J Hematol; 2018 Nov; 93(11):1427-1430. PubMed ID: 30039522 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]